STARTUP PROFILE

Precision Neuroscience

COUNTRY
USA
FOUNDED
2016
CATEGORY
Brain-Computer Interface
Developing the Layer 7 Cortical Interface, a minimally invasive, high-resolution brain–computer implant to restore communication and independence via thought.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series C+
MODALITY
ECoG
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Stroke
TARGET USER
Patients
REGULATORY STAGE
Investigational
Precision Neuroscience is differentiated by its thin, minimally invasive Layer 7 cortical implant designed to achieve high-resolution recording with less tissue disruption than penetrating arrays. It is one of the more credible near-term implantable BCI companies, positioned between invasive bandwidth and surgical practicality.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
13
Neurotech wants to challenge GLP-1s
27 October – 10 November 2026

Precision Neuroscience opened its first clinical site outside the US at Cleveland Clinic Abu Dhabi. The expansion will allow Precision to test its Layer 7 implant and procedures inside a new health system, as Abu Dhabi continues attracting life sciences research.

#
11
BCI reaches a new scale
30 September – 13 October 2026

Precision Neuroscience released a manuscript describing a human neural atlas built from 70 patients across twelve medical centers. The manuscript contains recordings from its Layer 7 interface, spanning more than 87,000 microelectrodes, 100,000 anatomical locations, and 180 hours of neural and behavioral data. The recordings cover regions from the cortex to the spinal cord. The dataset supports Precision's ambition to develop a whole-brain interface.

Articles featuring
Precision Neuroscience